These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 21732137)
1. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer. Sato N; Hayashi N; Imamura Y; Tanaka Y; Kinoshita K; Kurashige J; Saito S; Karashima R; Hirashima K; Nagai Y; Miyamoto Y; Iwatsuki M; Baba Y; Watanabe M; Baba H Ann Surg Oncol; 2012 Jun; 19(6):2060-5. PubMed ID: 21732137 [TBL] [Abstract][Full Text] [Related]
2. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
3. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis. Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240 [TBL] [Abstract][Full Text] [Related]
4. Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients. Hayama T; Iinuma H; Watanabe T Oncol Rep; 2007 Oct; 18(4):779-84. PubMed ID: 17786336 [TBL] [Abstract][Full Text] [Related]
5. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
7. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168 [TBL] [Abstract][Full Text] [Related]
9. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Shen C; Hu L; Xia L; Li Y Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519 [TBL] [Abstract][Full Text] [Related]
10. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382 [TBL] [Abstract][Full Text] [Related]
11. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients. Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578 [TBL] [Abstract][Full Text] [Related]
12. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473 [TBL] [Abstract][Full Text] [Related]
13. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Taniguchi T; Makino M; Suzuki K; Kaibara N Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326 [TBL] [Abstract][Full Text] [Related]
15. Intraoperative quantitative detection of CEA mRNA in the peritoneal lavage of gastric cancer patients with transcription reverse-transcription concerted (TRC) method. A comparative study with real-time quantitative RT-PCR. Ohashi N; Nakanishi H; Kodera Y; Ito S; Mochizuki Y; Koike M; Fujiwara M; Yamamura Y; Tatematsu M; Nakao A; Kato T Anticancer Res; 2007; 27(4C):2769-77. PubMed ID: 17695446 [TBL] [Abstract][Full Text] [Related]
16. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; RamÃrez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063 [TBL] [Abstract][Full Text] [Related]
17. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822 [TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255 [TBL] [Abstract][Full Text] [Related]
19. [Peritoneal lavage diagnosis with TRC (transcription reverse transcription concerted reaction) system for prediction of peritoneal recurrence in gastric cancer]. Hanada H; Fujiwara Y; Sohma I; Nakamura Y; Takeoka K; Iwatani Y; Hidaka Y Rinsho Byori; 2007 Nov; 55(11):1002-7. PubMed ID: 18154031 [TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies. Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]